Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Current Deferred Revenue: 2009-2025

Historic Current Deferred Revenue for Innoviva (INVA) over the last 12 years, with Sep 2025 value amounting to $13.6 million.

  • Innoviva's Current Deferred Revenue rose 1792.75% to $13.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.6 million, marking a year-over-year increase of 1792.75%. This contributed to the annual value of $1.1 million for FY2024, which is 11.82% down from last year.
  • Innoviva's Current Deferred Revenue amounted to $13.6 million in Q3 2025, which was up 334.27% from $3.1 million recorded in Q2 2025.
  • In the past 5 years, Innoviva's Current Deferred Revenue ranged from a high of $13.6 million in Q3 2025 and a low of $717,000 during Q3 2024.
  • In the last 3 years, Innoviva's Current Deferred Revenue had a median value of $1.3 million in 2023 and averaged $2.7 million.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first tumbled by 73.72% in 2024, then surged by 1,792.75% in 2025.
  • Quarterly analysis of 4 years shows Innoviva's Current Deferred Revenue stood at $2.1 million in 2022, then slumped by 39.02% to $1.3 million in 2023, then fell by 11.82% to $1.1 million in 2024, then soared by 1,792.75% to $13.6 million in 2025.
  • Its Current Deferred Revenue stands at $13.6 million for Q3 2025, versus $3.1 million for Q2 2025 and $1.0 million for Q1 2025.